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Objectives This study investigated the outcome for all patients undergoing catheter valve perforation for pulmonary atresia
with intact ventricular septum (PAIVS) 21 years after the first procedure at their center.
Background Catheter perforation for PAIVS is now an established procedure. However, the management of the borderline right
ventricle (RV) is controversial, and there may be a place for novel techniques such as stenting of the arterial duct.
Methods There were 37 successful valve perforations (total 39 patients). Median length of follow-up was 9.2 years (range 2.2
to 21.0 years). Seventeen patients had stenting of the arterial duct. The mean (SD) initial z-score for the tricuspid
valve was5.1 (3.4), and a further 142 sets of measurements were taken to assess the growth of the RV of survivors.
Results There were 8 deaths (21%), and no deaths after the first 35 days. There were no late arrhythmias or ischemic events.
Twenty-five patients (83% of survivors) have a biventricular circulation. For patients who had stenting of the arterial
duct, significant reductions in early reintervention (0 vs. 7 patients, p  0.009) and hospital stay (17.4  18.1 days
vs. 33.8  28.6 days, p  0.012) occurred, with no increase in mortality or morbidity. There was no catch-up growth
of the RV in patients who had a biventricular outcome (z-score increase 0.08/year, p  0.26).
Conclusions Long-term survival is good, and even small RVs may be amenable to this procedure. Multiple interventions may be
required to achieve biventricular circulation, but stenting of the arterial duct may reduce hospital stay and repeat
procedures. (J Am Coll Cardiol 2012;59:1468–76) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2012.01.022Pulmonary valve atresia with intact ventricular septum
(PAIVS) is a rare but heterogeneous condition with an
incidence of 3 to 8 per 100,000 births (1,2), and the
variability with this malformation necessitates a complex
decision-making process. Selection of the correct treatment
pathway for patients is critical for survival (3), and there is
a high early mortality without intervention (4).
The decision on the treatment pathway is based on the
morphology of the right ventricle (RV) and the presence or
absence of associated abnormalities (5). In many cases,
treatment of PAIVS is by establishing antegrade flow
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2011, accepted January 2, 2012.through the RV and across the pulmonary valve, with the
aim of optimizing the chance of a biventricular circulation.
However, some factors, such as right ventricular–dependent
coronary circulation (RVDCC), are contraindications to
decompression of the RV (6–9), and so a univentricular
pathway is pursued.
Historically, surgery has been used in the neonatal period
to establish forward flow across the pulmonary valve (PV).
As an alternative, our institution performed the first cath-
eter pulmonary valvotomy in the world for PAIVS in 1990
(10,11), and the technique is now the mainstay of treatment in
many centers for patients with favorable anatomy (12–20).The
technique has evolved, and stenting of the arterial duct has
been added as a source of additional pulmonary blood flow
in selected patients while RV function is being established
(21–28). However, there remains a lack of consensus re-
garding the best treatment pathway for those patients with
borderline anatomy (15,29).
This study reports on the long-term outcome for patients
treated at our institution, where an aggressive approach has
been adopted. All suitable patients, without any contraindicat-
v1469JACC Vol. 59, No. 16, 2012 Chubb et al.
April 17, 2012:1468–76 Pulmonary Atresia With Intact Ventricular Septum: Long-Term Outcomeing lesions, were put forward for catheter valvotomy. More
recently, our institution has also favored simultaneous stenting
of the arterial duct in selected cases. Over the long period of
follow-up, the outcomes analyzed include the final type of
circulation, the evolution and growth of the RV, and the safety
and efficacy of stenting of the arterial duct. The study also aims
to evaluate the outcomes of early decompression of the RV in
those patients judged to have borderline anatomy.
Methods
Patients. From May 1990 to March 2009, 56 patients
presenting with PAIVS were identified. All had simple
PAIVS (situs solitus, levocardia, concordant atrioventricular
and ventriculoarterial connections with confluent pulmonary
arteries); 39 were put forward for catheter valvotomy. The
remainder either did not survive the early neonatal period (n
2), or were treated surgically with a view to creating a
univentricular circulation. The criteria for surgery included
RVDCC (n 7), severe hypoplasia of the RV (unipartite RV)
or muscular atresia (n  5), or a severely dysplastic tricuspid
valve (TV) or severe Ebstein’s anomaly (n  3).
Final outcome was evaluated on June 1, 2011. Median
time elapsed since procedure was 9.2 years (range 2.2 to 21.0
years). No patient with 2 years follow-up was evaluated.
Of the 39 patients put forward for catheter valvotomy, in
2 there was failure to perforate the PV: 1 died prior to
perforation due to tamponade, and the other had surgery.
The baseline characteristics are outlined in Table 1.
There were 22 males and 17 females, with mean gestation
of 38.1 weeks (28 to 42 weeks) and mean weight at time of
procedure of 2.97 kg (0.86 to 4.47 kg). The mean z-score
(30) of the TV annulus at birth was 5.1 (3.4). RV to
coronary artery connections were identified in 5 patients,
but these were considered not to be an RVDCC. Two had
mild Ebstein’s anomaly, and 1 had Turner’s syndrome with
a bicuspid aortic valve. There were no other significant
associated abnormalities.
The median age at the procedure was 4 days (1 to 72 days),
with 5 of the early patients undergoing laser perforation of the
atretic valve. All the others underwent radiofrequency valve per-
foration. The arterial duct was stented at the initial procedure in
Summary of Baseline Characteristicsof Population for Catheter Valvotomy (N  39)Table 1 Summ ry of B seline Characteristicsof Population for Catheter Valvotomy (N  39)
Birthweight, kg 2.97 0.57
Gestational age, weeks 38.1 3.4
Antenatal diagnosis 20 (51)
Sex, male 22 (56)
Age at initial procedure, days 6.9 11
TV annulus size, cm 0.94 0.25
TV annulus z-score 5.1 3.4
TV/MV annulus ratio 0.71 0.22
Mean length of follow-up, yrs 10.7 6.1
Values are mean SD or n (%). Annulus measurements were obtained from the apical 4-chamber
iew.
MV  mitral valve; TV  tricuspid valve.14 patients, and at a later procedure
in 3 further patients. One patient
underwent a catheter pulmonary
valvotomy antenatally at 23 weeks,
using a 4  8-mm Tyshak balloon
(NuMED, Hopkinton, New York),
with an initial good result. The
membranous atresia of the PV re-
curred 5 weeks later, and a postnatal
intervention was performed at 9
days. She currently has a biventricu-
lar circulation.
Data collection. The pediatric
cardiology database of the Evelina
Children’s Hospital and Guy’s
Hospital was reviewed retrospec-
tively to identify all patients with PAIVS. The first catheter
valvotomy procedure was performed in May 1990, and a
minimum of 2 years follow-up was required for inclusion. Final
outcomes are correct as of June 1, 2011.
Data for those patients, who had been put forward for
catheter valvotomy, were gathered from the clinical notes
and hospital database, including baseline demographics.
The clinical course for each patient was recorded, including
significant complications (intra-procedural, vascular, sepsis,
neurological, other), length of intensive care unit and
in-patient stay, further catheter and surgical procedures, and
final outcome in terms of circulation type and disability.
Longitudinal data were also collected when recorded, including
weight, height, oxygen saturation levels, and valvar dimensions.
In total, 142 sets of measurements were collected.
Ethical approval was granted by Guy’s and St Thomas’s
Ethical Committee and Research and Development Com-
mittee (Reference RJ111/N028).
Baseline echocardiographic dimensions. The initial
echocardiogram after birth was reviewed for a representative
sample of 18 of the 39 patients, in order to assess repro-
ducibility of baseline data. The echocardiograms were mea-
sured independently by 3 investigators (H.C., J.M.S., and
S.A.Q.) on 2 separate occasions, and the mean of these
values was recorded. The tricuspid and mitral valves were
measured from the apical 4-chamber view in early diastole
(Fig. 1), the aortic valve in a long-axis parasternal view and
the PV in a short-axis parasternal view in early systole.
Measurements were performed offline using electronic cal-
ipers (Hewlett-Packard Sonos 7500, Philips, Andover,
Massachusetts) for echocardiograms performed before
2007, and using EchoPAC software package (GE Medical
Systems, Milwaukee, Wisconsin) for echocardiograms per-
formed since 2007. The z-scores were calculated from the
algorithms established by Daubeney et al. (30). Using the
averaged values of the 3 investigators as a gold standard,
the measurements were compared with those documented
in the clinical records contemporaneously. A Bland-Altman
analysis (31) was utilized and the agreement was assessed as
Abbreviations
and Acronyms
MV  mitral valve
NEC  necrotizing
enterocolitis
PAIVS  pulmonary atresia
with intact ventricular
septum
PV  pulmonary valve
RV  right ventricle
RVDCC  right ventricle–
dependent coronary
circulation
TV  tricuspid valveacceptable (mean bias of [averaged reviewed values] 
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measurements recorded in the patient notes at the time of
initial assessment were accepted for the rest of the cohort.
Longitudinal measurements over time of the valve annulus
of each survivor were also made, through review of the
original echocardiogram. Where this was not possible,
contemporaneous measurements were accepted. Using the
weight and height for the child recorded at the time of the
echocardiogram, the valve z-score for each point in time was
calculated.
Procedure. The technique of the catheter procedure has
been described in detail in earlier publications from our
center (10,12,22,32). Briefly, cardiac catheterization was
performed under general anesthesia in all neonates with full
heparinization and antibiotic cover. Vascular access of the
femoral vein and femoral artery was obtained percutane-
ously, and 4-F sheaths and 4-F catheters inserted. Initial
angiography of the RV body and outflow tract was per-
formed in order to determine the size and morphology of
the RV and the presence or absence of sinusoidal connections
from the RV to the coronary arteries (Figs. 2A and 2B). Cath-
eters were positioned through the femoral venous and
arterial routes just below and above the atretic PV, respec-
tively. Once stable and acceptable positions of the catheters
were obtained, a laser (argon generator, “hot tip” wire) or
radiofrequency wire (5 W for 2 to 5 s was used, although
occasionally 10 W were required) was advanced through the
venous catheter and the heated tip gently pushed to perfo-
rate the atretic valve. Using a gooseneck snare and a
super-floppy guidewire, an arteriovenous circuit was estab-
Figure 1 Echocardiogram Showing 4-Chamber Apical View in E
The measurements of the tricuspid and mitral valves were taken from the inner se
Measurements were taken by 3 independent observers (H.C., J.M.S., and S.A.Q.)lished in the majority of cases to allow the safe passage ofthe appropriately sized low-profile Tyshak balloon across
the valve. The PV was dilated with a balloon to 100% to
120% of its size.
Simultaneous stenting of the arterial duct was performed
in selected patients from 2000. The duct was stented if it
was judged by the interventionalist that the patient was
likely to require prostaglandin therapy for more than 2
weeks. The judgment was subjective, and was based upon
the size and morphology of the duct and perceived adequacy
of the RV size and function. If the decision had been made
to stent the arterial duct, the prostaglandin infusion was
stopped at the beginning of the procedure. The valve was
perforated and ballooned as described in the previous text,
then the duct was assessed angiographically and the stent
size selected (Figs. 3A to 3D). The stent was generally
positioned across the duct from the aortic side, with
multiple handshot angiograms in order to confirm good
stent position before inflation.
Statistical analysis. Statistical analyses were performed
using Stata v. 11 (StataCorp, College Station, Texas).
Summary statistics are expressed as mean (SD) for nor-
mally distributed variables, and as median (range) for
non-normally distributed variables. Two sample compari-
sons utilized either the t test or Wilcoxon rank sum
(Mann-Whitney) test dependent upon normality of the
variable’s distribution. Fisher exact test was employed for
binary variables. Growth trajectories for the TV annulus
were modeled using a random coefficients model (xtmixed
command), and comparisons of TV growth trajectories were
made between patients who attained biventricular versus
iastole
nd lateral wall margins of the annulus.
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Catheter valvotomy was successful in 37 of 39 patients,
defined by the completion of valve perforation and
balloon dilation of the RV outflow tract. In 1, the
procedure was abandoned due to unsatisfactory position-
ing of the catheters for attempted valvotomy (TV z-score:
11.3). The other patient (weight at procedure 860 g, TV
-score: 16.4) died in the catheter laboratory following
ardiac tamponade due to guidewire perforation of the
Figure 2 The Borderline RV
(A) Right ventricular (RV) angiogram demonstrating a “bipartite RV,” with mus-
cular obliteration of the apical portion of the RV, and a RV to coronary artery
connection (RVCAC) that did not constitute a RV-dependent coronary circula-
tion. (B) RV angiogram following perforation of the pulmonary valve with for-
ward flow.V outflow tract. iemodynamics. Prior to perforation of the PV, the mean
V systolic pressure was 101 (28) mm Hg, and the mean
ortic systolic pressure 68 (17) mm Hg. The mean pulmo-
ary artery systolic pressure prior to perforation was 37
15) mm Hg. Following perforation and dilation of the
V, the systolic RV, pulmonary artery, and aortic pressures
ere 51 (20) mm Hg, 36 (9) mm Hg, and 63 (12) mm
g, respectively. The median size of the balloon used to
ilate the PV was 7 mm (range 5 to 10 mm).
ortality. There were 8 deaths (21%) in total. One patient
described in the previous text) died at surgery following an
nsuccessful valve perforation. Of the other 7 deaths, 2
ccurred due to cardiac tamponade, 3 due to sepsis (including
with necrotizing enterocolitis [NEC]), and 1 following a
erebral hemorrhage at 22 days. One occurred after the patient
eveloped profound hypotension, resistant to inotropes, and
he impression at post-mortem examination was that this was
ost likely attributable to a “figure of 8 circulation,” with a
tented arterial duct and regurgitant PV and TV.
omplications. Cardiac tamponade occurred in 6 patients
uring the procedure, including those 2 who later died. In 1
atient, the ductal stent embolized to the aorta and was
uccessfully retrieved. There were 9 who required throm-
olysis for femoral vascular occlusion following the proce-
ure, and all but 2 recovered normal pulses.
Significant long-term comorbidities following the proce-
ure were neurological deficits in 2 patients. Both had a
emiparesis, 1 due to a thalamic hemorrhage (day 1 after
rocedure, following thrombolysis with streptokinase) and 1
ue to a cerebral abscess (diagnosed day 92 after the
rocedure). One had cerebral palsy, but this was thought to
e due to an undiagnosed syndrome. One has suffered from
eizures that were controlled on medication.
ong-term outcome. The 30-day mortality for all 39
ttempted procedures was 15% (6 deaths). Of the 37
uccessful procedures, there were 7 (19%) deaths, all occur-
ing within the first 35 days post-procedure. Six occurred
uring the first 10 years of experience, and 2 in the
ubsequent 10 years. The causes of death are as detailed
bove, and there were no late deaths. There were no late
rrhythmia or ischemic events. Figure 4 summarizes the
nal outcome for the population.
At the most recent follow-up, 25 (83%) of the 30
urvivors had a biventricular circulation. Eighteen patients
ith a biventricular circulation required a further procedure,
ither surgical or catheter based (Fig. 5). Repeat balloon
ilation of the PV was required in 13, and 6 required
alloon dilation or late stenting of the arterial duct. Inser-
ion of a Blalock-Taussig shunt was required in only 3
atients. Two achieved biventricular circulation but needed
surgical right ventricular overhaul, at 25 and 39 months,
nd this technique has been described in detail in other
ublications (29,33); 1 required a surgical reconstruction of
he RV outflow tract at 6 months. Twelve required closure
f an atrial septal defect. A device occlusion was performed
n 5, at a mean age of 6.6 (2.7) years. The remaining 7 had
1472 Chubb et al. JACC Vol. 59, No. 16, 2012
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a mean age of 2.5 (2.0) years.
Of the 5 (13% of all procedures) patients not achieving
biventricular circulation, 4 have a 1-and-a-half ventricle
circulation completed at a mean of 23 (15) months, and 1
has a Fontan circulation, completed at 49 months.
Stenting of the arterial duct. The arterial duct was stented
at the initial procedure in 14 patients, and at a subsequent
procedure in a further 3 (at 11, 27, and 44 days post-
procedure, respectively). Four further patients in the early
years of the technique had ballooning of the arterial duct
alone. In 1, stenting of the duct was attempted at the initial
procedure, but the stent embolized to the descending aorta
and was retrieved successfully. The decision was made not
to stent the duct of this patient. There were 2 deaths in the
cohort that were stented, 1 of which may be attributable to
the stenting of the duct, with a “figure of 8 circulation” as
described previously. The other death was due to klebsiella
sepsis. Table 2 summarizes the characteristics and outcomes
of patients, divided according to whether the arterial duct
Figure 3 Stenting of the Arterial Duct
(A and B) Aortic angiogram demonstrating the morphology of the arterial duct and
Ductal stent in position, inserted from aortic side, prior to inflation. (D) Aortic ang
ventricle through the perforated pulmonary valve.was stented.The length of stay in pediatric intensive care and in hospital
was significantly shorter for those in whom the arterial duct
was stented, and early reintervention was significantly reduced.
There was no increase in mortality or incidence of NEC in the
stented group. In the long term, 1 patient required redilation of
the ductal stent at 12 months, and this was performed at the
same procedure as balloon dilatation of the RV outflow tract.
No patient required the insertion of further ductal stents at a
later procedure. All but 1 ductal stent occluded spontaneously
following cessation of aspirin. One patient required occlusion
of the ductal stent with a coil performed at 40 months at the
same procedure as a device closure of the atrial septal defect.
There was no report of late branch pulmonary artery stenosis.
Predictors of final outcome. Patients with a smaller initial
TV annulus and PV annulus z-scores were less likely to
achieve biventricular circulation and more likely to have an
unsuccessful procedure/death (Table 3). For patients with a
reduced TV/mitral valve ratio, there was also a trend
towards a non-biventricular outcome, but this was not
significant. Higher saturations (90%) at 1 year were highly
quent measurements. Note the secure wire position across the arterial duct. (C)
demonstrating flow through the ductal stent. Note the regurgitation into the rightsubse
iogramcorrelated with an eventual biventricular outcome. Those
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biventricular outcome. There was no relationship between
birthweight or gestation and outcome.
Growth trajectories. TV growth trajectories via the random
coefficients model are shown in Figure 6. Patients achieving
biventricular outcome demonstrated higher TV z-scores at
aseline (3.92 vs. 7.01, p  0.001). Those achieving a
niventricular circulation demonstrated a decrease in TV
-score with time (approximating 0.38 units per year, p 
.001). Conversely, patients achieving biventricular circulation
howed a trend towards an increase in TV size and z-score
ith time. However, this was not sufficient to constitute
catch-up” growth, as the z-score did not change significantly
gradient 0.08 per year, p  0.26).
iscussion
his study represents the longest follow-up to date of a
opulation with PAIVS who have undergone catheter
ulmonary valvotomy (14,16–18). However, this popula-
ion also represents a departure from management algo-
ithms generally used in other studies. This difference is in
reatment of the borderline RV and the role of stenting of
Figure 4 Flowchart Summarizing
Outcome for the Study Populationhe arterial duct at the initial procedure. dhe borderline RV. It is important to choose the correct
reatment pathway, balancing the need for short-term safety
gainst the long-term goal of maximizing quality of life.
shburn et al. (3) demonstrated the importance of balanc-
ng the desire for a biventricular repair against the cardiac
natomy, and that centers that strive too hard to achieve an
mbitious repair run the risk of high mortality in their
urgical patient population. This principle should also apply
o catheter valvotomy procedures.
However, decompressing the RV, unless contraindicated
y anatomical features such as RVDCC, will be advanta-
eous in the long term regardless of the final outcome
29,34). The advantages include improved left ventricular
unction (16), growth of the RV (34–36), reduction in
ndocardial fibroelastosis, and stimulation of development
f the pulmonary vasculature (37). There are additional
enefits for the patients if these can be achieved by catheter
ntervention rather than surgery (38).
If the likelihood of achieving biventricular circulation is
ot an essential criterion for catheter valvotomy, the ques-
ion still arises as to what criteria should be used to identify
n RV as being unsuitable for the procedure. A number of
utoff points have been suggested in other publications,
ncluding a TV annulus of at least 11 mm (19) or a z-score
f at least 3.5 (14,17). In our study, these values appear
xtremely conservative, but it is important to bear in mind
he algorithm with which a z-score is calculated. Our study
as chosen to use the algorithms calculated from the data of
aubeney et al. (30), in common with the majority of
omparable publications (5,14,16,34,36). However, some
tudies have used algorithms calculated from autopsy mea-
urements (18,39) or have not made explicit which set of
lgorithms have been used. This is relevant, as the z-score of
he TV can vary by as much as 3 standard deviations
etween different algorithms.
Over the 21 years since the first procedure, our center has
aintained an aggressive approach towards catheter valvot-
my. Patient selection has remained unchanged, and all pa-
ients without any contraindicating features have been put
orward for the procedure. This is despite the relatively high
ortality rate in the early era. The procedure has evolved to
ecome an accepted and relatively safe treatment strategy in
any centers.
tenting of the arterial duct. The arterial duct was stented
n 14 patients at the initial procedure, including the majority
85%) from 2004 onwards. This approach represents a
eparture from that advocated in other publications, al-
hough a recent paper from Alwi et al. (27) has also
emonstrated promising results following stenting at the
nitial procedure. In patients in whom the arterial duct was
tented, there was a significantly reduced re-intervention
ate and hospital stay.
The most significant complication is the development of
igh-flow cardiac failure in 1 patient, who died. The precise
ause of the hemodynamic instability in this patient is
ifficult to determine as the stent used in the duct was of a
1474 Chubb et al. JACC Vol. 59, No. 16, 2012
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birthweight (4  16-mm Liberte Stent, Boston Scientific,
Natick, Massachusetts), and the initial post-procedure pul-
monary and tricuspid regurgitation was no more severe than
for most patients undergoing this procedure. Alwi et al.
reported a single death in their cohort with a comparable
pathology. In our cohort, there was no increased incidence
of NEC, renal failure, or vascular complications. In the long
term, all but 1 duct closed spontaneously following cessation
Figure 5 The Number of Subjects Who Underwent Further Proc
ASD  atrial septal defect; BT  Blalock-Taussig; RV  right ventricle; RVOT  rig
Summary of Characteristics of PatientsWho Did or Did Not Undergo Sten ng of theArterial Duct Foll wing Successful Valve P rforation
Table 2
Summary of Characteristics of Patients
Who Did or Did Not Undergo Stenting of the
Arterial Duct Following Successful Valve Perforation
Stented
(n  17)
Not Stented
(n  20) p Value
Year 2005 (1992–2009) 1998 (1990–2009) 0.003
zTV 5.11 2.53 4.13 2.92 0.28
Days ICU 4.6 2.9 9.1 8.0 0.029
Days in hospital 17.4 18.1 33.8 28.6 0.012
NEC 2 (12) 6 (30) 0.25
Early reintervention 0 7 (35) 0.009
Late reintervention 11 (65) 8 (40) 0.13
Biventricular outcome 11 (65) 14 (70) 0.92
Death 2 (12) 5 (25) 0.32
Values are median (range), mean SD, or n (%). p Values in bold are statistically significant. zTV
indicates the z-score of the TV annulus (Daubeney algorithm [30]). Early reintervention is defined as
further catheter or surgical intervention in the first 100 days following the valvotomy. Five of the
reinterventions were the insertion of a Blalock-Taussig shunt. Stented group includes 3 patients
who were stented at a later procedure, at 11 days, 27 days, and 44 days post-procedure,
respectively, and these are not included as early reinterventions. Late reintervention is defined as
further catheter or surgical intervention 100 days following the valvotomy (4 patients in the
unstented group had both early and late reinterventions).
ICU  intensive care unit; NEC  necrotizing enterocolitis; TV  tricuspid valve annulus.of aspirin. The final case required closure of the arterial duct
with a coil, and the proportion requiring interventional
closure is similar to other studies (21,26).
Growth of the RV. The TV annulus measurement was
used as the surrogate for RV size in this study. Several
studies in the past have failed to demonstrate catch-up
growth of the TV in terms of an increase in the TV z-score
over time (16,29,35,36,40), and this was replicated in this
study. It is important to note that catch-up growth of the
RV is not an essential criterion for establishing a biventricu-
lar circulation. In separating out those that did not achieve
a biventricular circulation, cause and effect are confounded.
However, for those with a non-biventricular outcome, the
fall in z-score generally predates the creation of a cavopul-
monary shunt. These findings are in contrast to Huang et al.
(40) who found the greatest potential for catch-up growth
in those with the smallest RV.
Achieving biventricular circulation and the long-term
outcome. Eighty-three percent of survivors in our study
currently have a biventricular circulation, similar to compa-
rable studies (14,16–18). The improvement in survival
figures over time reflects the learning curve associated with
a new and technically demanding technique that continued
to develop (41,42).
Following successful perforation of the PV, those with a
smaller RV tend to require more interventions in their treat-
ment pathway. This staged approach should not be seen as a
failure of the initial procedure, but rather as the tailoring of
s After the Pulmonary Valvotomy
tricular outflow tract; TCPC  total cavopulmonary circulation.edure
ht ventreatment to fit such a heterogeneous group (26,29,43). It is
lus; zPA
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survival and final outcome advantage for those patients that
have been diagnosed antenatally. This is in contrast to earlier
studies (44) and requires further research.
Late complications are rare. Those patients with forward
flow across a small TV into a restrictive RV might be
expected to be more likely to develop a dilated right atrium
and arrhythmias. However, to the best of our knowledge,
this has not been reported, and none of the patients in this
cohort has suffered from this complication. There has been
concern in the literature that patients with PAIVS may go
on to develop myocardial perfusion abnormalities (45), but
the cohort most likely to develop this are those with
RVDCC, who were excluded from this study. There was no
event suggestive of myocardial hypoperfusion in either the
Figure 6 Calculated Growth Trajectories
of the Tricuspid Valve
Z-scores are calculated using the algorithm derived by Daubeney et al. (30).
Solid lines represent predicted values (from the random coefficients model);
dashed lines indicate 95% confidence intervals.
Baseline Characteristics and Predictive Value for Final OutcomeTable 3 Baseline Characteristics and Predictive Value for Final
Died/Unsuccessful
n  9 (23%)
N
Gestation, weeks 37.8 6.4
Birthweight, kg 2.88 0.91
Antenatal diagnosis 2 (22%)
Male 6 (67%)
Age at procedure, days 14.7 22.6
Duct stented 2 (22%)
RV pressure before procedure 112 35
Change in RV pressure, mm Hg 58.4 40.7
zPA 2.76 0.63
zTV 7.36 5.4
TV/MV annulus ratio 0.63 0.25
Saturations at 1 yr, % NA
Follow-up, yrs NA
Values are mean  SD or n (%). p Values in bold are statistically significant. For the statistical ana
calculated using the algorithm of Daubeney et al. (30).
RV  right ventricle; TV/MV ratio ratio of the size of the TV annulus to the mitral valve (MV) annuearly or late stages of follow-up, although no patient has
been formally investigated for this.
Conclusions
Over the time period of this study, the technique of catheter
pulmonary valvotomy has evolved from a pioneering inter-
vention to become a mainstay of treatment for PAIVS at
many institutions. Safety continues to improve, and a
balance is required between providing the RV with the best
possible chance of supporting the cardiac output against the
increased risk of the procedure in borderline cases. This
study supports a more aggressive approach to achieving
2-ventricle circulation, with intervention in some cases with
a small RV that otherwise may not have been considered for
catheter valvotomy. Additionally, prophylactic stenting of
the arterial duct should be considered in those who are
judged most likely to require early reintervention. In the
long term, mortality outside of the acute phase of treatment
is extremely low, and late complications are rare.
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